PharmaCyte Biotech, Inc. (PMCB)

Company Overview
Nuvilex is an innovative company which aims at ionitiating a paradigm shift, generating revenue at the same time as creating cancer and other cell related solutions to treat important human diseases, such as pancreatic cancer while retaining our connections to natural products. The present effort underway will give rise to dramatic advances in cancer therapy and benefit millions of people worldwid
read more

Watch the video to learn about the probability of PharmaCyte Biotech, Inc. (PMCB) Chart Signal as of Mar 30, 2015

Hotstocked Precision will calculate the probabilities of PharmaCyte Biotech, Inc. (PMCB)

Rating:
Size: 656KB
Version: 1.1
Platform: Win/Mac
Downloads: 800,000+
FREE DOWNLOAD

QUOTE

As of 03:37PM EDT March 30, 2015
$ 0.1399   0 (1.38%)
Today's Open: 0.1435 Previous Close: 0.138
Today's High: 0.145 Volume: 2,089,155
Today's Low: 0.1371 Avg Vol: 2,601,712
52 Week High: 0.493 Bid (size): 0
52 Week Low: 0.095 Ask (size): 0

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: Meadows Corporate Park I, 12510 Prosperity Boulevard, Silver Spring, MD 20904, United States
Mailing Address: -
Phone: 240-696-6859
Fax: -
Website: http//www.nuvilex.com

Company Details:

Symbol: PMCB
SIC: -
State location: MD
Sector: -
State of Inc: NV
Employees: 1
Type: -

Key executives:

Name Age Position
2015
Dr. Gerald W. Crabtree 2015 COO
Patricia Gruden 2015 Chairman of the Board of Directors and CFO
Robert F. Ryan 2015 President, CEO

Watch the video to learn about the probability of PharmaCyte Biotech, Inc. (PMCB) Chart Signal as of Mar 30, 2015

This free program will calculate the probabilities of PharmaCyte Biotech, Inc. (PMCB) stock chart

Rating: Platform: Win/Mac
Price: FREE Version: 1.1
Size: 656KB Downloads: 800,000+
FREE DOWNLOAD

LATEST ARTICLES

Pharmacyte Biotech Inc (OTCMKTS:PMCB) Surges On Near-Record Volume March 27, 2015

Yesterday the stock of Pharmacyte Biotech Inc (OTCMKTS:PMCB) made a rather impressive move in the right direction. The ticker was able to add nearly 29% to its value sitting at $0.147 when the closing bel rang. Equally as impressive was the sheer amoun... read more

Pump for PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) Keeps Rolling February 25, 2015

Miraculously, the stock pump targeting PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) is still going. In the meantime, the stock is still dropping. In early February PMCB pulled itself up by its own hair and bounced off its 52-week low. Sadly, under the pressu... read more

Cream Consulting Still Dogging PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) February 20, 2015

The pumpers are not letting go. No matter how much the share price of PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) tumbles on the charts, they are always ready to promote the company's stock to their subscribers. The interminable pump targeting PMCB is still... read more

PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) Gets a New Pumper February 16, 2015

The promotional emails targeting PharmaCyte Biotech, Inc. (OTCMKTS:PMCB) keep coming. The difference is that on Friday the paying party was new and the compensation paid out to promoters had shrunk significantly. In the last trading session PMCB shifted... read more

LATEST STOCK PROMOTIONS

PMCB Ramping Up Mighty Fast Mar 30, 2015, 08:51

  50% Barely Scratched The Surface Here Rise Up, Trader!   Remember, we got PharmaCyte Biotech Inc. (PMCB) in our sights this morning . . . I think this $0.15 biotech is a great way to start the week.   How come? PMCB has enormous clinical targets ahead of it. They’re working on a cure for diabetes as well as pancreatic cancer.   TWO HUGE TARGETS, BOTH OF THEM read more

Promoter: Stock Commander Paying Party: Cream Consulting Max Profit: Pending Gain at close: Pending
Stock: pmcb Compensation: Avg $ Volume for Period: UNKNOWN

PMCB Riding A Breakout Biotech Wave Mar 29, 2015, 16:22

  50% Last Week Opens The Big Sky Get Ready, Trader!   PharmaCyte Biotech Inc. (PMCB) is swinging at the same targets as Wall Street’s biotech darlings --  and us rednecks get a taste at CENTS per share!   PMCB IS WORKING ON A CURE FOR DIABETES. AND THEN IT’S GOT CLINICAL TRIALS BREWING FOR PANCREATIC CANCER.   With analyst after analyst getting on the bandwagon, read more

Promoter: Stock Commander Paying Party: Cream Consulting Max Profit: Pending Gain at close: Pending
Stock: pmcb Compensation: Avg $ Volume for Period: UNKNOWN

PMCB Goes On A 30% Two Day Run - New Momo Play 9:30AM Tomorrow Mar 26, 2015, 20:42

    New Alert: 9:30 EST Friday   --------------------------------------------------------------   Good evening readers and welcome new subscribers.   Yesterday we wanted you to direct 100% of your attention to a 10 cent biotech company. Our report landed at exactly 9:28AM and we also sent a text message alert with a link to the report.   PMCB traded from .106 to .115 throughout the entire day. The last trade read more

Promoter: Actual Gains Paying Party: Cream Consulting Max Profit: 1.32% Gain at close: Pending
Stock: pmcb Compensation: $4,000 Avg $ Volume for Period: UNKNOWN

Nuvilex, Inc. (NVLX) MESSAGE BOARD

Post # Subject Re Name Date
1 Such a deep anewsr! GD&RVVF 0
2 I love these areltics. How many words can... 0
3 Well, I think the Fed has to do a lot... 0
4 I just love how optimistic Jim Cramer and... 0
5 Dear Minamar,Can you give me some more... 0
6 Well mamiadcaa nuts, how about that. 0
7 I hope so 0
8 I'm a Dollarniare now! The scams on otc... 0
9 yes we are ging to be millionaires but it... 1
10 chemo kills weed does not 0
11 What happened to this stock today? It's... 0
12 Oh what happened? 2
13 Tanking like a ROCK!! Alpha Articles out!!! 4
14 FDA possible approval response to NVLX... 1
15 Yes it can 0
16 Man! I'd personally write some options... 0
17 20 Ducats? You jest my dear buffoon! 0
18 Oh Sheeheeheeheet! NVLX is fo' real ?... 0
19 50:1 split? Ha ha 0
20 with a 50:1 Reverse stock split! Yes... 0